Literature DB >> 23095036

Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: difference by histology.

Akifumi Miyakawa1, Yuta Shibamoto, Katsura Kosaki, Chisa Hashizume.   

Abstract

To investigate the possible influences of various factors on tumor response to radiation, regression speeds and long-term local control rates of primary adenocarcinoma and squamous cell carcinoma of the lung after stereotactic body radiotherapy were evaluated. Ninety-one patients (65 men and 26 women) with a median age of 76 years were serially examined using computed tomography at 2, 4 and 6 months after treatment. Tumor histology was adenocarcinoma in 62 patients and squamous cell carcinoma in 29 patients. The prescribed dose was 48 Gy in four fractions given twice a week for T1 tumors (≤ 3 cm) and 52 Gy in four fractions given twice a week for T2 tumors (3-5 cm). Tumor shrinkage speed and 3-year local control rates were similar between T1 and T2 tumors and between patients with normal pulmonary function and those with impaired function. Squamous cell carcinomas shrank faster than adenocarcinomas at 2 and 4 months after radiation, but mean relative tumor size at 6 months and local control rates at 3 years did not differ significantly between the two histologies. Tumors in patients with a higher hemoglobin level tended to shrink faster but the control rates were not different. It is concluded that, although squamous cell carcinoma shrinks faster than adenocarcinoma, the two types of lung cancer are of similar radiosensitivity in terms of long-term control rates. Radiosensitivity should not be evaluated by early tumor response.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Year:  2012        PMID: 23095036     DOI: 10.1111/cas.12048

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  8 in total

1.  Correspondence: Abnormal Nuclear Variations in Response to Radiotherapy: As a Tool in Treatment Planning and Assessment of Prognosis.

Authors:  Laxman Khanal
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer.

Authors:  Sana D Karam; Zachary D Horne; Robert L Hong; Nimrah Baig; Gregory J Gagnon; Don McRae; David Duhamel; Nadim M Nasr
Journal:  Lung Cancer (Auckl)       Date:  2013-08-06

3.  Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy.

Authors:  Hiromitsu Kanzaki; Masaaki Kataoka; Atsushi Nishikawa; Kotaro Uwatsu; Kei Nagasaki; Noriko Nishijima; Takashi Ochi; Teruhito Mochizuki
Journal:  Int J Clin Oncol       Date:  2016-04-28       Impact factor: 3.402

4.  Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy.

Authors:  Kotoha Tatekawa; Hiromitsu Iwata; Takatsune Kawaguchi; Satoshi Ishikura; Fumiya Baba; Shinya Otsuka; Akifumi Miyakawa; Maho Iwana; Yuta Shibamoto
Journal:  Radiat Oncol       Date:  2014-01-07       Impact factor: 3.481

5.  Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.

Authors:  Norio Katoh; Itaru Soda; Hiroyasu Tamamura; Shotaro Takahashi; Yusuke Uchinami; Hiromichi Ishiyama; Kiyotaka Ota; Tetsuya Inoue; Rikiya Onimaru; Keiko Shibuya; Kazushige Hayakawa; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2017-01-05       Impact factor: 3.481

6.  Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Ran Zhang; Jingjing Kang; Shengxiang Ren; Ligang Xing; Yaping Xu
Journal:  Ann Transl Med       Date:  2022-01

7.  SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma.

Authors:  Zihang Zeng; Jianguo Zhang; Jiali Li; Yangyi Li; Zhengrong Huang; Linzhi Han; Conghua Xie; Yan Gong
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

Review 8.  Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?

Authors:  Kim Mullins
Journal:  J Adv Pract Oncol       Date:  2015-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.